Frequency and Antimicrobial Resistance Patterns of Methicillin-Resistant Staphylococcus aureus in Tehran
AbstractBackground: Methicillin-Resistant Staphylococcus aureus (MRSA) is the one of most commonly isolated organisms from clinical samples which can cause life- threatening infections. The emergence and spread of antibiotic resistance makes the treatment of these infections more complicated. In this study, we aimed to determine the patterns of antibiotic resistance among MRSA isolates from Tehran, Iran.Methods: From December 2012 to April 2014, 120 clinical samples were collected. MRSA was identified by cefoxitin disc diffusion. Antimicrobial susceptibility testing was performed on MRSA isolates for eight other antibiotics by disc diffusion method according to CLSI (2013) recommendations. Also, the minimum inhibitory concentration (MIC) was determined for vancomycin by MIC test strips.Results: According to disc diffusion, 60 (50%) isolates showed resistance to cefoxitin. Among these isolates, the rate of resistance to nitrofurantoin, vancomycin, teicoplanin, doxycycline, trimethoprim, erythromycin, clindamycin, and ciprofloxacin were 0%, 0%, 0%, 28.3%, 28.3%, 58.3%, 63.3%, and 70%, respectively. All isolates were susceptible to vancomycin according to disc diffusion and MIC.Conclusion: Compared to other reports from Iran, our study indicated a moderate rate for MRSA. However, the rates of resistance to generally prescribed antibiotics in these isolates were high. In this situation, it is recommended to monitor the antibiotic resistance in these hospitals.
Diep BA, Gill SR, Chang RF, et al.Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin- resistant Staphylococcus aureus. Lancet 2006; 367 (9512): 731-9.
Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5 (12): 751-62.
Noskin GA, Rubin RJ, Schentag JJ, et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis 2007; 45 (9): 1132-40.
Oberoi L, Kaur R, Aggarwal A.Prevalence and antimicrobial susceptibility pattern of methicillin- resistant Staphylococcus aureus (MRSA) in a rural tertiary care hospital in North India. Int J Appl Biol Pharma Tech 2011; 3 (1): 200-10.
Velasco D, del Mar Tomas M, Cartelle M, et al. Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother 2005; 55 (3): 379-82.
Deurenberg R, Vink C, Kalenic S, et al. The molecular evolution of methicillin‐resistant Staphylococcus aureus. Clin Microbiol Infect 2007;13 (3): 222-35.
Kali A, Stephen S, Umadevi S, et al. Changing trends in resistance pattern of methicillin resistant Staphylococcus aureus. J Clin Diag Res 2013; 7 (9): 1979-82.
Grundmann H, Aires-de-Sousa M, Boyce J, et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public- health threat. Lancet 2006; 368 (9538): 874-85.
Gould IM. Community-acquired MRSA: can we control it?. Lancet 2006; 368 (9538): 824-6.
Saravanan R, Raveendaran V.Antimicrobial resistance pattern in a tertiary care hospital: An observational study. J Basic Clin Pharm 2013; 4 (3): 56-63.
Askari E, Soleymani F, Arianpoor A, et al. Epidemiology of mecA- methicillin resistant Staphylococcus aureus (MRSA) in Iran: A systematic review and meta-analysis. Iran J Basic Med Sci 2012; 15 (5): 1010-9.
Ohadiam Moghadam S, Havaei SA, Pourmand MR. Prevalence of methicillin-resistant Staphylococcus aureus carrying panton-valentine leukocidin gene in cutaneous infections in the city of Isfahan. J Med Bacteriol 2012; 1 (1, 2): 9-16.
Tiwari HK, Sapkota D, Sen MR.High prevalence of multidrug- resistant MRSA in a tertiary care hospital of northern India. Infect Drug Resist 2008; 1: 57-61.
Onanuga A, Oyi A, Olayinka B, et al.Prevalence of community-associated multi-resistant Staphylococcus aureus among healthy women in Abuja, Nigeria. Afr J Biotechnol 2005; 4 (9):942-945.
Afrough P, Pourmand MR, Zeinalinia N, et al. Molecular typing of clinical and nasal carriage isolates of Staphylococcus aureus by spa gene patterns. J Mazand Univ Med Sci 2012; 22 (94): 28-34. [Article in Persian]
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing.23rd informational supplement M100-S23, CLSI, Wayne, PA,2013.
Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003; 9 (12): 1179-86.
Aligholi M, Emaneini M, Jabalameli F, et al. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract 2008; 17 (5): 432-4.
Japoni A, Alborzi A, Orafa F, et al.Distribution patterns of methicillin resistance genes (mecA) in Staphylococcus aureus isolated from clinical specimens. Iran Biomed J2004; 8 (4): 173-8.
Rahimi F, Bouzari M, Maleki Z, et al. Antibiotic susceptibility pattern among Staphylococcus spp. with emphasis on detection of mecA gene in methicillin resistant Staphylococcus aureus isolates. Iran J Clin Infect Dis 2009; 4 (3):143-50.
Saderi H, Owlia P, Nadoushan MRJ. Difference in epidemiology and antibiotic susceptibility of methicillin resistant and methicillin susceptible Staphylococcus aureus isolates. Iran J Clin Infect Dis2009; 4 (4): 219-23.
Rahimi F, Bouzari M, Katouli M, et al. Antibiotic resistance pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates in Tehran, Iran. Jundishapur J Microbiol 2013; 6 (2): 144-9.
Farhadian A, Nejad Q, Peerayeh S, et al. Determination of vancomycin and methicillin resistance in clinical isolates of Staphylococcus aureus in Iranian hospitals. Br Microbiol Res J 2014; 4 (4): 454-61.
Asakri E, Tabatabai SM, Arianpoor A, et al. VanA-positive vancomycin- resistant Staphylococcus aureus systematic search and review of reported cases. Infect Dis Clin Pract 2013; 21 (2): 91-3.
Vahdani P, Saifi M, Aslani MM, et al. Antibiotic resistant patterns in MRSA isolates from patients admitted in ICU and infectious ward. Tanaffos 2004; 3 (11): 37-44.
Rossi F, Diaz L, Wollam A, et al.Transferable vancomycin resistance in a community-associated MRSA lineage. N Engl J Med 2014; 370 (16): 1524-31.
|Issue||Vol 2 No 3-4 (2013)|
|Methicillin-Resistant Staphylococcus aureus Microbial Sensitivity Tests Vancomycin|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|